| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1365714 | Bioorganic & Medicinal Chemistry Letters | 2007 | 4 Pages |
Abstract
Fifteen novel C5 analogues of thiolactomycin have been synthesised and assessed for their in vitro mtFabH and in vivo Mycobacterium bovis BCG activity, respectively. The biological analysis of this library reaffirms the requirement for a linear Ï-rich system containing hydrogen bond accepting substituents attached to the para-position of the C5 biphenyl analogue to generate compounds with enhanced activity.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Veemal Bhowruth, Alistair K. Brown, Suzanne J. Senior, John S. Snaith, Gurdyal S. Besra,